Impact of Treatments Before Allogeneic HSCT in Patients With Higher-Risk Myelodysplastic Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of treatments before allogeneic hematopoietic stem cell transplantation in patients with higher-risk myelodysplastic syndrome
Leuk. Res 2022 Dec 07;124(xx)106997, Y Zhang, C Liu, R Zhang, Y Shi, X Li, J Yu, D Wan, X XieFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.